Search

The article analyzes early cancer detection and population screening programs, highlighting overdiagnosis as the most significant harm of these programs. It is mentioned that screening programs are more effective in finding biologically benign cancers than aggressive ones. The author concludes that cancer detection in the general population has become a distraction and that resources should be directed towards other aspects of healthcare. The "Choosing Wisely" initiative is also discussed, which aims to reduce low-value healthcare and promote professionalism in medicine. The importance of continuity of care and carefully sharing diagnostic test results with the patient is emphasized. [Extracted from the article]

The article focuses on thyroid cancer and discusses topics including the epidemic of overdiagnosis of the disease, the watch-and-wait approach for thyroid cancer, and how genetic information may reshape thyroid cancer treatment and follow-up care in the future.

The article discusses a case study of a 70 year old patient, who was presented to an eye care center to establish care. It reveals that the patient was on multiple glaucoma medications, six months before he came to an eye specialist. His medical examinations revealed best-corrected visual acuity and crystalline lenses with moderate nuclear sclerosis in both eyes. It investigates whether the diagnosis rates are higher in Northeast and Middle Atlantic states, or patients are overdiagnosed there.

The article offers news brief on medical-related topics as of May 1, 2016. Topics include the reduction in outcome risk of systolic pressure such as coronary artery disease, heart failure and stroke, the prevention of an overtreatment of malaria to avoid potential disaster of failure, and the role of arboviruses on the wide spread of chikungunya virus in Africa.

The article reports on a study conducted by researchers in the U.S. which examines the Medicare claims filed by eye care providers between 2002 to 2008. Findings reveal that clinicians are more likely to either underdiagnose or overdiagnose the forms of glaucoma. It indicates that residents in New England and the Mid-Atlantic states are more likely to be diagnosed with the disease.